Walter Ambrosius to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Walter Ambrosius has written about Adrenergic beta-Antagonists.
Connection Strength
0.196
-
Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT, Whelton PK. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014 Oct; 11(5):532-46.
Score: 0.118
-
Goff DC, Massing MW, Bertoni AG, Davis J, Ambrosius WT, McArdle J, Duren-Winfield V, Sueta CA, Croft JB. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project. Am Heart J. 2005 Oct; 150(4):717-24.
Score: 0.064
-
Bertoni AG, Duren-Winfield V, Ambrosius WT, McArdle J, Sueta CA, Massing MW, Peacock S, Davis J, Croft JB, Goff DC. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina. Am J Cardiol. 2004 Mar 15; 93(6):714-8.
Score: 0.014